Drug Compounding
Societies take stand against off-brand GLP-1s over safety concerns
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.
FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk and the FDA announced.
FDA confirms end of tirzepatide shortage
The FDA has confirmed there is no longer a shortage of tirzepatide and has set dates for companies to cease distribution of compounded forms of the agent, according to an announcement from the agency.
FDA cautions public, providers to avoid use of compounded salt forms of semaglutide
The FDA is advising people using semaglutide to avoid some compounded formulations due to the use of ingredients that may cause adverse events, according to a safety notice.
FDA: Avoid using certain Greenpark Compounding Pharmacy products
The FDA recommended health care providers and individuals avoid using compounded products said to be “sterile, produced and distributed nationwide by Prescription Labs Inc.” that does business as Greenpark Compounding Pharmacy.
Compounded glaucoma therapies can reduce medication shortages, prices
Compounded off-label glaucoma therapies can reduce medication prices and lead to more widespread treatment, according to a speaker.
Options available, on the way to treat dry eye secondary to glaucoma
Dry eye disease and glaucoma both increase in prevalence with age. They are also commonly present in the patient who presents for cataract surgery.
Physicians need to mitigate risk with compounded drugs
I have long been an advocate of compounded medications as a way to offer my patients cost-effective, preservative-free medications with convenient dosing.
Newer brands, compounded drugs improve efficacy, compliance
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.